Individualized Genotype-guided Antiplatelet Therapy in Patients With Acute Coronary Syndrome
A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 3120 participants.
Also called NCT07939516
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 3,120 participants
- Sponsor
- Medisch Spectrum Twente
- Registry
-
NCT07939516
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Netherlands
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07939516. Randomized; no masking; primary purpose treatment. Start 2026-11-15 (anticipated); primary completion 2029-11-15 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Individualized Genotype-guided Antiplatelet Therapy in Patients With Acute Coronary Syndrome
- Acronym
- IGNITION
- Condition
- Acute Coronary Syndromes (ACS)
- Condition
- Unstable Angina Pectoris
- Condition
- Myocardial Infarction (MI)
- Condition
- STEMI
- Condition
- NSTEMI
- Intervention (Drug)
- Genotype guided P2Y12 therapy
- Intervention (Drug)
- Standard therapy group
- Lead sponsor
- Medisch Spectrum Twente
- Collaborator
- Ziekenhuisgroep Twente
Record details
- Record id
cardio:ct-nct07939516- Content hash
db85ec7ec0dd502682f668cd135ec291b60fe5d97c628cd51932ccd4e3ecb52a